CTOs on the Move

Johnson Memorial Hospital (IN)

www.johnsonmemorial.org

 
Johnson Memorial Hospital (IN) is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Johnson Memorial Hospital (IN) is based in Franklin, IN. You can find more information on Johnson Memorial Hospital (IN) at www.johnsonmemorial.org
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

Amsyn Inc

Amsyn Inc is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Touchstone Health HMO

Touchstone Health HMO is a White Plains, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Catasys

Catasys leads the health care industry in improving health and reducing claims costs for health plan members with behavioral health disorders that cause or exacerbate co-existing medical conditions. OnTrak™, a 52-week intensive outpatient program, treats an overlooked population: members suffering from chronic disorders such as substance dependence, anxiety and depression who rarely seek care. These members cost health plans millions of medical dollars primarily due to preventable ambulance usage, medical ER visits and medical inpatient admissions. Catasys uses a proprietary analytics platform and predictive modeling to identify high utilizers of medical healthcare services with costs that can be significantly reduced by addressing the underlying behavioral health disorder(s). Through proactive outreach, we engage and treat these individuals in our patient-centric program that integrates evidence-based medical interventions, psychosocial skill building and care coaching by nurses.

Walnut Hills Retirement Cmmty

Walnut Hills Retirement Cmmty is a Walnut Creek, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Symbiomix Therapeutics

Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.